DUBLIN, Oct. 20, 2015 /PRNewswire/ --
Research and Markets(http://www.researchandmarkets.com/research/92tk62/2016_emerging_us) has announced the addition of the "2016 Emerging US Diagnostic Testing Market: Segment Forecasts and Supplier Shares by Test" report to their offering.
This new report provides an overview of the US diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments:
- Blood Banking
- Cancer
- Chemistry
- Coagulation
- Drugs of Abuse
- Endocrine
- Hematology and Flow Cytometry
- Immunoprotein
- Infectious Diseases
- Molecular Diagnostics
- TDM
Companies Mentioned
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher/Life Technology
- Wallac/PE
- Wako
For more information visit http://www.researchandmarkets.com/research/92tk62/2016_emerging_us
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article